Skip to content
VuFind
  • Language
    • English
    • Español
Advanced
  • Search
  • Polymer Drugs in the Clinical...
  • Description
  • Cite this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to MARC
    • Export to RDF
    • Export to BibTeX
    • Export to RIS
Polymer Drugs in the Clinical Stage Advantages and Prospects /
QR Code

Polymer Drugs in the Clinical Stage Advantages and Prospects /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Maeda, Hiroshi. (Editor), Kabanov, Alexander. (Editor), Kataoka, Kazunori. (Editor), Okano, Teruo. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 2003.
Edition:1st ed. 2003.
Series:Advances in Experimental Medicine and Biology, 519
Subjects:
Pharmacology.
Polymers  .
Medical biochemistry.
Oncology  .
Pharmacy.
Pharmacology/Toxicology.
Polymer Sciences.
Medical Biochemistry.
Oncology.
Online Access:https://doi.org/10.1007/b105364
  • Holdings
  • Description
  • Table of Contents
  • Similar Items
  • Staff View
Description
Physical Description:VIII, 226 p. online resource.
ISBN:9780306479328

Similar Items

  • Inhibitors of Protein Kinases and Protein Phosphates /
    Published: (2005)
  • The Selection of Doses in Chronic Toxicity/Carcinogenicity Studies Age-Associated (Geriatric) Pathology: Its Impact on Long-Term Toxicity Studies /
    Published: (1984)
  • Mouse Liver Tumors Relevance to Human Cancer Risk Symposium of the European Society ofToxicology Held in Rome, February 2-5, 1986 /
    Published: (1987)
  • Interpretation and Extrapolation of Chemical and Biological Carcinogenicity Data to Establish Human Safety Standards The Use of Short-Term Tests for Mutagenicity and Carcinogenicity in Chemical Hazard Evaluation /
    Published: (1984)
  • New Approaches to Drug Discovery /
    Published: (2016)

© Copyright 2024, Todos los Derechos Reservados SIIDCA-CSUCA

Loading...